ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Hanel, M
Hoffknecht, MM
Peters, SO
Fiedler, F
Hanel, A
Kruger, WH
Zeller, W
Braumann, D
Illiger, HJ
Metzner, B
Schubert, JC
Schmitz, N
Weh, HJ
Kroger, N
Zander, AR
机构：
[1] KUCHWALDKRANKENHAUS,CLIN INTERNAL MED 3,DEPT HEMATOL,CHEMNITZ,GERMANY
[2] UNIV HAMBURG,HOSP EPPENDORF,BMT CTR,D-20246 HAMBURG,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4559 / 4559
页数：1
相关论文
共 50 条
  • [1] Anticipation occurs in familial Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Wiernik, PH
    Wang, SQ
    Hu, XP
    Marino, P
    BLOOD, 1997, 90 (10) : 3964 - 3964
  • [2] ASHAP: AN EFFECTIVE SALVAGE THERAPY FOR REFRACTORY HODGKIN LYMPHOMA
    Cakir, F. B.
    Ozulker, T.
    Ozturk, G.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 890 - 890
  • [3] Thymic residual masses in adult patients with Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD).
    Tartas, N
    Chacón, C
    Domenichini, E
    Pascuccelli, H
    Sporn, V
    Mazzucco, J
    Korin, J
    Barazzutti, L
    Ferro, H
    Busso, P
    Foncuberta, C
    Kusminsky, G
    Chacón, R
    Avalos, JS
    BLOOD, 1999, 94 (10) : 255B - 255B
  • [4] Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Coad, NAG
    Jones, TJ
    Muir, KR
    Parkes, SE
    Smith, K
    Raafat, F
    Mann, JR
    PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1997, 17 (06): : 893 - 902
  • [5] Standardized uptake value (SUV) for staging of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Cortés-Blanco, A
    Martínez-Lázaro, R
    Zhuang, HM
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 279P - 279P
  • [6] ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma
    Choi, CW
    Paek, CW
    Seo, JH
    Kim, BS
    Shin, SW
    Kim, YH
    Kim, JS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (05) : 621 - 624
  • [7] Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma
    Hopfinger, G
    Heinz, R
    Pfeilstocker, M
    Schlogl, E
    Waldner, R
    Pittermann, E
    ANNALS OF ONCOLOGY, 1996, 7 (04) : 423 - 424
  • [8] Phase II study of thalidomide in patients with recurrent Hodgkin's disease (HD) and non-Hodgkin's lymphomas (NHL).
    Pro, B
    Younes, A
    Albitar, M
    Hagemeister, FB
    Rodriguez, MA
    McLaughlin, P
    Clemons, M
    Samaniego, F
    Cabanillas, F
    BLOOD, 2001, 98 (11) : 246B - 246B
  • [9] Autologous transplants followed by mini-allografts for Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Carella, AM
    Corsetti, MT
    Lerma, E
    Cavaliere, M
    BLOOD, 2000, 96 (11) : 407A - 407A
  • [10] Primary refractory disease in non-Hodgkin lymphoma (NHL)
    d'Amore, F.
    Brown, P.
    Pedersen, L. M.
    Pulczynski, B. B.
    Pedersen, M.
    Gadeberg, O.
    Bukh, A.
    Hansen, M.
    Pulczynski, S.
    Ingeberg, S.
    Andersen, T. M.
    Frederiksen, M.
    Moeller, M. B.
    Mortensen, L. S.
    ANNALS OF ONCOLOGY, 2008, 19 : 132 - 132
12345